Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR Transfemoral System in Patients With Severe Symptomatic Mitral Regurgitation - APOLLO-EU Trial

NCT05496998 is registered in ClinicalTrials.gov with Medtronic Cardiovascular as lead sponsor.

NCT NCT05496998
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05496998 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR Transfemoral System in Patients With Severe Symptomatic Mitral Regurgitation - APOLLO-EU Trial
Lead sponsor
Medtronic Cardiovascular
Phase
Not applicable
Overall status
Recruiting
Start date
February 7, 2023
Completion date
December 31, 2038
Enrollment
400 (estimated)
Sites
37

Conditions

As the registry lists them; a condition with its own page is linked.

mitral regurgitation